Skip to main content

Table 3 Sensitivity (%) of self-reported psychoactive medication use by characteristics of study subjects compared to the National prescription register data during the four months preceding the self-report

From: The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women

Use of psychoactive medication according to the National prescription data

 

Any

Antidepressant

Other

Characteristics

%

(n)

Pvaluea

%

(n)

Pvaluea

%

(n)

Pvaluea

Self-reported use of psychoactive medication

44.2

(724/1,638)

 

54.8

(426/777)

 

29.0

(250/861)

 

Age (years)

 

< 0.001

  

0.254

  

< 0.001

   57 - 62

49.3

(429/871)

 

56.6

(248/438)

 

36.0

(156/433)

 

   63 - 68

38.5

(295/767)

 

52.5

(178/339)

 

22.0

(94/428)

 

Marital status

 

< 0.001

  

0.021

  

< 0.001

   Single

64.3

(99/154)

 

70.0

(56/80)

 

47.3

(35/74)

 

   Married / cohabitating

42.3

(413/977)

 

54.8

(251/458)

 

26.2

(136/519)

 

   Divorced

50.0

(87/174)

 

51.7

(45/87)

 

40.2

(35/87)

 

   Widoved

36.7

(114/311)

 

48.9

(69/141)

 

22.9

(39/170)

 

Body mass index (kg/m2)

0.011

  

0.195

  

0.115

   < 25

41.1

(170/414)

 

50.8

(93/183)

 

27.7

(64/231)

 

   25 – 29.99

42.1

(262/623)

 

54.4

(162/298)

 

27.1

(88/325)

 

   ≥ 30

49.8

(240/482)

 

59.6

(137/230)

 

34.5

(87/252)

 

Alcohol consumption (g/month)

< 0.001

  

0.075

  

< 0.001

   None

48.1

(400/832)

 

57.1

(228/399)

 

33.9

(147/433)

 

   < 360

38.0

(264/695)

 

51.3

(164/320)

 

21.9

(82/375)

 

   ≥ 360

51.2

(22/43)

 

37.5

(9/24)

 

63.2

(12/19)

 

Number of self-reported diseases

0.911

  

0.365

  

0.670

   0

45.9

(34/74)

 

44.4

(16/36)

 

34.2

(13/38)

 

   1 − 2

43.4

(258/594)

 

53.5

(154/288)

 

29.1

(89/306)

 

   ≥ 3

44.0

(410/931)

 

56.1

(245/437)

 

27.7

(137/494)

 

Smoking

  

0.190

  

0.410

  

0.075

   no

43.6

(621/1,425)

 

54.3

(373/687)

 

27.9

(206/738)

 

   yes

48.4

(103/213)

 

58.9

(53/90)

 

35.8

(44/123)

 

HT use

  

0.727

  

0.872

  

0.357

   no

44.0

(546/1,240)

 

55.2

(309/560)

 

29.9

(203/680)

 

   yes

45.1

(178/395)

 

54.4

(118/217)

 

26.1

(47/180)

 

Life satisfaction

 

0.016

  

0.222

  

0.472

   satisfied

42.5

(102/240)

 

63.0

(58/92)

 

25.6

(53/207)

 

   intermediate

42.0

(402/958)

 

53.1

(229/431)

 

28.7

(142/494)

 

   dissatisfied

50.1

(212/423)

 

54.9

(134/244)

 

31.4

(45/143)

 

Number of self-reported prescribed medication

<0.001

  

<0.001

  

<0.001

   0

0.0

(0/110)

 

0.0

(0/35)

 

0.0

(0/75)

 

   1 − 2

34.2

(202/590)

 

40.8

(115/282)

 

24.4

(75/308)

 

   ≥ 3

55.7

(522/938)

 

67.6

(311/460)

 

36.6

(175/478)

 

Amount of purchased medication b

< 0.001

  

< 0.001

  

< 0.001

   low

23.4

(120/513)

 

35.4

(85/240)

 

12.9

(40/309)

 

   moderate

42.5

(259/610)

 

56.8

(151/266)

 

39.6

(82/207)

 

   high

67.0

(345/515)

 

70.1

(190/271)

 

37.1

(128/345)

 

History of work disability pension

< 0.001

  

< 0.001

  

< 0.001

   no

38.7

(384/992)

 

51.4

(231/449)

 

24.3

(132/543)

 

   somatic cause

39.1

(181/463)

 

47.4

(99/209)

 

25.6

(65/254)

 

   psychiatric cause

86.9

(159/183)

 

80.7

(96/119)

 

82.8

(53/64)

 
  1. Abbreviations: HT, hormone therapy.
  2. a P value from the chi-square test between the subgroups.
  3. b Tertile cutoffs for amount of use (DDD/4 months): psychoactive medication <34 (low), 34–100 (moderate), >100 (high), antidepressants <33, 33–99.9, ≥100, other psychoactive medication <33, 33–99.99, ≥100.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us